Notably, the stronger positive correlation between SPT1 mRNA expression and C16-ceramide and HOMA-IR strengthens the hypothesis that C16-ceramide generated via de novo pathway could be inducing IR in obese individuals with T2D. The gene discussed is SPTLC1; the disease is type 2 diabetes mellitus.